MENTAL HEALTH CENTRE IS HIGHLY COMMENDED IN INTERNATIONAL AWARDMENTAL HEALTH CENTRE IS HIGHLY COMMEN
Added: (Thu Feb 28 2002)
Pressbox (Press Release) -
London, 28 February 2002 - A Horsham centre offering a service to people with severe and complex mental health problems and their carers, is one of only ten UK charities to be highly commended and receive £1,000 in the GlaxoSmithKline (GSK) International IMPACT Awards 2002.
Horsham Parkhaven, which has been commended for making a demonstrable impact on the health of its local community was set up by the local Curate of the parish church in 1991. The organisation offers support and self help in a flexible, safe, caring and confidential environment to its members.
Parkhaven offers services that are diverse and responsive to each member. Activities have ranged from building a sensory garden to taking part in Operation Raleigh International in Belize.
The International IMPACT Awards, now in their fifth year, are run by GSK in partnership with the King’s Fund, a leading independent health charity. The awards reward small-to medium-sized registered charities with a proven track record in community health care. Ten UK charities receive £25,000 while ten highly commended projects receive £1000. The scheme is running concurrently with a sister initiative in Philadelphia, USA, which is the US headquarters of GlaxoSmithKline.
Claire Hitchcock, Director, Global Community Partnership European and International, GlaxoSmithKline says: “Once again we were impressed by the high standard of achievement by these small healthcare organisations. GlaxoSmithKline is dedicated to paying tribute to the commitment of these charities who make such a difference to people’s lives despite the constraints of their size.”
-Ends-
Editor’s notes
The International IMPACT Awards play a significant part in GSK’s Global Community Programme which aims to support the company’s commitment to improving the quality of human life by enabling people to do more, feel better and live longer.
The acronym IMPACT derives from the criteria that winners must have demonstrated: Innovation, Management, Partnership, Achievement, Community Focus and Targeting Need.
In the UK GSK has a continuing programme of charitable activities, which places special emphasis on scientific education and medical research. In addition, GSK seeks to fund initiatives for improving healthcare in the UK and supports a variety of projects in the visual and performing arts, as well as the environment.
As one of the world’s leading research based pharmaceutical and healthcare companies, GSK is dedicated to delivering innovative medicines and products that help millions of people around the world live longer, healthier and happier lives.
For company information visit GlaxoSmithKline at www.gsk.com
Issued by Prowse & Co on behalf of GlaxoSmithKline
For more information please contact:
Vicki Fletcher / Deborah Fields, Prowse & Co, 01372 363386 or e-mail
vicki@prowse.co.uk or deborah@prowse.co.uk
News release is available online at http://www.prowse.co.uk/newsf.html
London, 28 February 2002 - A Horsham centre offering a service to people with severe and complex mental health problems and their carers, is one of only ten UK charities to be highly commended and receive £1,000 in the GlaxoSmithKline (GSK) International IMPACT Awards 2002.
Horsham Parkhaven, which has been commended for making a demonstrable impact on the health of its local community was set up by the local Curate of the parish church in 1991. The organisation offers support and self help in a flexible, safe, caring and confidential environment to its members.
Parkhaven offers services that are diverse and responsive to each member. Activities have ranged from building a sensory garden to taking part in Operation Raleigh International in Belize.
The International IMPACT Awards, now in their fifth year, are run by GSK in partnership with the King’s Fund, a leading independent health charity. The awards reward small-to medium-sized registered charities with a proven track record in community health care. Ten UK charities receive £25,000 while ten highly commended projects receive £1000. The scheme is running concurrently with a sister initiative in Philadelphia, USA, which is the US headquarters of GlaxoSmithKline.
Claire Hitchcock, Director, Global Community Partnership European and International, GlaxoSmithKline says: “Once again we were impressed by the high standard of achievement by these small healthcare organisations. GlaxoSmithKline is dedicated to paying tribute to the commitment of these charities who make such a difference to people’s lives despite the constraints of their size.”
-Ends-
Editor’s notes
The International IMPACT Awards play a significant part in GSK’s Global Community Programme which aims to support the company’s commitment to improving the quality of human life by enabling people to do more, feel better and live longer.
The acronym IMPACT derives from the criteria that winners must have demonstrated: Innovation, Management, Partnership, Achievement, Community Focus and Targeting Need.
In the UK GSK has a continuing programme of charitable activities, which places special emphasis on scientific education and medical research. In addition, GSK seeks to fund initiatives for improving healthcare in the UK and supports a variety of projects in the visual and performing arts, as well as the environment.
As one of the world’s leading research based pharmaceutical and healthcare companies, GSK is dedicated to delivering innovative medicines and products that help millions of people around the world live longer, healthier and happier lives.
For company information visit GlaxoSmithKline at www.gsk.com
Issued by Prowse & Co on behalf of GlaxoSmithKline
For more information please contact:
Vicki Fletcher / Deborah Fields, Prowse & Co, 01372 363386 or e-mail
vicki@prowse.co.uk or deborah@prowse.co.uk
News release is available online at http://www.prowse.co.uk/newsf.html